Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof

A type 2 diabetes, adjuvant therapy technology, applied in food preparation, medical preparations containing active ingredients, metabolic diseases, etc., can solve the problems such as no blood sugar lowering research report, no type 2 diabetes health care products, etc., to achieve easy quantitative The effect of reducing fasting blood sugar level, easy to take

Active Publication Date: 2013-07-10
GENSUN INST OF BIOMEDICINE
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The research on loofah seeds is currently mainly focused on the single-chain ribosome-inactivating protein isolated from loofah seeds. There is n

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof
  • Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof
  • Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] The preparation of embodiment 1 capsule of the present invention

[0022] Loofah Seed Powder 67% Beta-Cyclodextrin 33%

[0023] The specific preparation steps are as follows: take the loofah seeds of loofah, wash them, place them in an oven at 40°C, remove the shells after 15 hours, put the loofah seeds in a grinder, crush them for 10-20 seconds, and pass them through a 100-mesh sieve. Obtain loofah seed powder. After mixing according to the above-mentioned proportioning ratio again, get the fine medicine powder and pack into capsules, and each capsule contains 0.15 g of luffa seed powder.

Embodiment 2

[0024] The preparation of embodiment 2 tablet of the present invention

[0025] Loofah Seed Powder 95% Starch 5%

[0026] Adopt the method of Example 1 to obtain loofah seed powder, mix auxiliary materials by percentage: starch and sodium benzoate, after uniform mixing, compress into tablets to make tablets, each tablet contains 0.15g of loofah seed powder.

Embodiment 3

[0027] The preparation of embodiment 3 tablet of the present invention

[0028] Loofah Seed Powder 95% Vitamin C 5%

[0029] The specific preparation steps are as follows: take the loofah seeds of loofah, wash them, place them in an oven at 50° C., remove the shells after 10 hours, put the loofah seeds in a grinder, grind them for 10-20 seconds, and pass through a 100-mesh sieve. Obtain loofah seed powder. After mixing according to the above-mentioned proportioning ratio again, get the fine medicine powder and pack into capsules, and each capsule contains 0.15 g of luffa seed powder.

[0030] Clinical Trial Results 1

[0031] Number of people treated: 20 people, age: 30-70 years old, the clinical diagnosis is type 2 diabetes patients, and the department does not use commercially available hypoglycemic drugs and health care products to varying degrees, such as: metformin hydrochloride, sulfonylureas, insulin injections Wait. Take the present invention in combination, take o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a healthcare product for the auxiliary treatment of type 2 diabetes, and a preparation method thereof, and relates to the medical healthcare field. The preparation method of the healthcare product comprises the following steps: taking towel gourd seeds of towel gourds, cleaning, baking in a 20-50DEG C baking box, shelling, grinding the shelled towel gourd seeds to form fine powder, and adding auxiliary materials to prepare a pharmaceutically acceptable formulation. The cooperation of the healthcare product and other blood sugar reducing medicines allows the fasting blood sugar of a type 2 diabetic patient to be stably reduced, and the effect to be more substantial than the single use of the blood sugar reducing medicines and blood sugar reducing healthcare products, and has no side effects.

Description

technical field [0001] The invention relates to a health product for auxiliary treatment of type 2 diabetes, in particular a health product prepared by mixing Chinese herbal medicines as raw materials with appropriate auxiliary materials. The invention also relates to a preparation method and a use method of the health product. Background technique [0002] Diabetes, known as "diabetes" in ancient times, is caused by the interaction of genetic and environmental factors. Hyperglycemia is the main clinical sign of diabetes. Due to its high incidence and serious complications, diabetes has become a serious disease that endangers human health after tumors and cardiovascular and cerebrovascular diseases. The absolute or relative insufficient secretion of insulin and the decreased sensitivity of target tissue cells to insulin caused by diabetes can cause a series of metabolic disorder syndromes such as protein, fat, water and electrolyte. If not effectively treated, it will even...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/42A61K47/40A61K47/44A23L1/29A61P3/10A61K131/00A23L33/00
Inventor 汤建石马永张昊王耀方
Owner GENSUN INST OF BIOMEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products